A detailed history of Meridian Financial Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Meridian Financial Partners LLC holds 32,568 shares of PFE stock, worth $858,492. This represents 0.48% of its overall portfolio holdings.

Number of Shares
32,568
Previous 32,823 0.78%
Holding current value
$858,492
Previous $975,000 3.28%
% of portfolio
0.48%
Previous 0.58%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$27.7 - $31.39 $7,063 - $8,004
-255 Reduced 0.78%
32,568 $943,000
Q2 2024

Jul 19, 2024

BUY
$25.26 - $29.6 $829,108 - $971,560
32,823 New
32,823 $975,000
Q2 2023

Jul 24, 2023

BUY
$36.12 - $41.79 $1.06 Million - $1.23 Million
29,374 New
29,374 $1.08 Million
Q2 2022

Jul 29, 2022

BUY
$46.53 - $55.17 $483,725 - $573,547
10,396 New
10,396 $540,000
Q1 2022

May 02, 2022

SELL
$45.75 - $56.69 $482,250 - $597,569
-10,541 Closed
0 $0
Q4 2021

Jan 27, 2022

SELL
$41.32 - $61.25 $9,297 - $13,781
-225 Reduced 2.09%
10,541 $564,000
Q3 2021

Oct 25, 2021

BUY
$39.25 - $50.42 $8,831 - $11,344
225 Added 2.13%
10,766 $446,000
Q2 2021

Jul 21, 2021

SELL
$35.91 - $40.68 $4,524 - $5,125
-126 Reduced 1.18%
10,541 $433,000
Q1 2021

Apr 21, 2021

BUY
$33.49 - $37.77 $4,420 - $4,985
132 Added 1.25%
10,667 $416,000
Q4 2020

Jan 21, 2021

SELL
$33.47 - $42.56 $1,673 - $2,128
-50 Reduced 0.47%
10,535 $385,000
Q3 2020

Nov 02, 2020

BUY
$31.75 - $37.25 $7,715 - $9,051
243 Added 2.35%
10,585 $401,000
Q2 2020

Jul 21, 2020

BUY
$30.12 - $36.54 $311,501 - $377,896
10,342 New
10,342 $364,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Meridian Financial Partners LLC Portfolio

Follow Meridian Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Financial Partners LLC with notifications on news.